Goodwin Procter·FDA / LIFE SCIENCES REGULATORY
FDA Issues FAQ Guidance for Cell and Gene Therapy
The US Food and Drug Administration has published a new guidance document answering frequently asked questions on the development of cellular and gene therapy products, covering topics from IND submissions to clinical trial design.
fdacgtgene-therapycell-therapyregulatory-guidancelife-sciencesdrug-development
Read the original firm alert → Tuesday, September 1, 2026